Multinational drug giant Pfizzier have been searching for the next big drug, and believe that they have found it.
The new drug, with the chemical name Codafil-dioxymethyl, is due to go on sale after extensive trials have proven it safe and effective at preventing a common problem for women of a certain age: leakage.
"An in depth study has shown that a lot of women suffer from leakage, either generally during the day, or when they sneeze," said Pfizzier spokesperson Uri Nate, "Our latest product enhances the body's natural mechanisms for preventing leakage and in our trials has greatly reduced or eliminated the problem entirely."
With the marketing campaign about to get under way, Pfizzier advertising executives have been busy coming up with a name for the new product that would be catchy and memorable. After discarding ideas such as Leak Stop and Leek Away, they have eventually settled on Niagara.
"We feel that this name is consistent with our other product lines, and will allow people to associate this product with our product lines," said Nate. "It also neatly encapsulates what the product does."